Cannabis for Inflammatory Bowel Disease

The academic paper "The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective" discusses the potential use of cannabis as a complementary therapy for Inflammatory Bowel Disease (IBD), a condition that includes Crohn's disease and ulcerative colitis. Cannabis works by interacting with two receptors, CB1 and CB2, found in the brain, enteric nervous system, gastrointestinal cells, and immune cells, potentially reducing symptoms such as gut motility, secretions, and inflammatory edema. However, the authors note that the small sample size of previous studies makes it hard to definitively conclude its efficacy and safety. They suggest that future research should focus on cannabis derivatives and endocannabinoids to maximize pain relief and minimize psychotropic side effects, and call for larger, long-term, randomized, placebo-controlled trials using standardized cannabinoid compositions.REFERENCE:Rauf A, Nisar M, Shaeel M, Athar A, Rehman MMU, Faheem F. The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective.. Cureus 16(10):e71068. 2024 Oct DOI: 10.7759/cureus.71068 PMID: 39624503. https://doi.org/10.7759/cureus.71068Content curated by: Dr. Cameron Jones, PhD. Public Health Expert, Fungal Biologist, and Science Communicator. CEO of Biological Health Services, a consultancy and lab specializing in indoor air quality. Adjunct Faculty at the National Institute of Integrative Medicine, Australia. Founder, BioMedix & House of Pot, Bangkok For more insights on public health and cutting-edge research, visit drcameronjones.com and drcameronjones.tv This podcast is part of an innovative science communication initiative powered by Google's Notebook LM, an AI-driven tool that helps bring complex research to life by creating dynamic conversations and easily digestible summaries. Stay tuned for more engaging discussions at the intersection of science, health, and wellness. Get full access to Science Exposed at www.drcameronjones.ai/subscribe